Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

PharmEnable Therapeutics is a biopharmaceutical company leveraging AI to create small molecule therapeutics for previously inaccessible drug targets. Their proprietary AI-driven platform, chemSEEK,…

PharmEnable Therapeutics is a biopharmaceutical company leveraging AI to create small molecule therapeutics for previously inaccessible drug targets. Their proprietary AI-driven platform, chemSEEK,…
Stage: Seed-stage biopharma
Technology: AI-driven small-molecule discovery (chemSEEK)
Therapeutic focus: Cancer and neurological diseases
HQ: Cambridge, United Kingdom
Recent funding: Seed round (lead: MP Healthcare Venture Management)
Discovery of small-molecule therapeutics for targets considered difficult or previously inaccessible to small molecules.
2016
Biotechnology
Investor syndicate includes Wren Capital, University of Cambridge Enterprise, Parkwalk Advisors, O2h Ventures, Martlet Capital, Jonathan Milner, Heyford Trust, Arrowfield Capital and others.
“Lead investor: MP Healthcare Venture Management; participation from academic- and region-focused investors and angel/backer names”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
400+
New This Week